Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Frontier Smart Technologies Grp Ltd

14 Jun 2019 11:40

RNS Number : 3446C
Science Group PLC
14 June 2019
 

 

14 June 2019

 

Science Group plc

 

Investment in Frontier Smart Technologies Group Limited

("Frontier")

 

 

 

Science Group plc (Science Group") notes the announcement by Frontier on 14 June 2019 (the "Frontier Announcement") of a preliminary approach from another party in relation to a corporate transaction. In contrast to the announcement made by Frontier on 20 May 2019 disclosing Science Group's interest, the Frontier Announcement this morning does not identify the potential bidder or provide details of the proposed price. Science Group also notes that the Frontier Announcement this morning also does not provide detail on conditionality or structure.

 

However, Frontier does notify shareholders that the approach is at a preliminary stage and that there can be no certainty that the approach will result in a formal offer for Frontier, nor as to the terms of any such offer if made. Furthermore, Frontier highlights that it is urgently seeking to clarify deliverability of this second approach, a very significant point in the opinion of Science Group.

 

With regard to deliverability, Science Group is currently the largest shareholder of Frontier, holding approximately 28.3% of the voting share capital. Science Group does not intend to sell its shares to any other potential bidder or vote in favour of any alternative transaction, including any vote on the disposal of assets of Frontier. In particular, Science Group notes that it will not be possible for another bidder to implement the transaction as a statutory merger or scheme of arrangement without the cooperation of Science Group, since each of these transactions would require the approval of at least 75% of Frontier shareholders voting.

 

Science Group also notes that, whilst another bidder could potentially gain voting control of Frontier by making a contractual offer, any subsequent delisting from AIM would also require the approval of at least 75% of Frontier shareholders voting, therefore also requiring Science Group cooperation. If de-listing did not occur, the integration of Frontier into another business with at least one substantial minority shareholder would, in Science Group's opinion, be likely to be challenging and would be subject to material legal and operational constraints.

 

Science Group also highlights the potential risks to Frontier of a protracted process, taking into account the financial position of Frontier as reported in the trading update on 9 May 2019. In that announcement, Frontier forecast an EBITDA trading loss of $2.2 million in the first half of 2019 and net debt at 30 April 2019 of $3.9 million. Frontier's bank facility is £5 million, approximately $6 million, although the Frontier announcement on 9 May did not provide any detail as to the headroom relative to the bank covenants, despite the reported challenging trading environment and deteriorating cash position.

 

As a result, Science Group reiterates the uncertainty regarding the deliverability of the second approach, as well as the potential risks to Frontier from further delay. Therefore, Science Group again encourages the board of directors of Frontier to engage with Science Group to complete a transaction with Science Group in a timely manner.

 

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

Panmure Gordon (UK) Limited

Dominic Morley / Alina Vaskina (Nominated Adviser)

Erik Anderson (Corporate Broking)

 

 

Tel: +44 (0) 20 7886 2500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBGGDLCXBBGCS
Date   Source Headline
26th Jun 20077:00 amPRNFinal Results
29th May 20077:00 amPRNProduct Collaboration
3rd May 20077:00 amPRNFuture Waves Design Win
20th Apr 20074:48 pmRNSHolding(s) in Company
23rd Mar 20075:04 pmRNSHolding(s) in Company
14th Mar 20074:36 pmRNSExercise of Options
26th Feb 20077:00 amPRNKey Development Milestone
21st Dec 200612:20 pmRNSResult of EGM
19th Dec 20067:02 amRNSToumaz Wins Oracle Award
5th Dec 20065:18 pmRNSNotice of EGM
22nd Nov 20065:41 pmRNSExercise of Options
3rd Nov 200611:55 amRNSExercise of Options
26th Oct 20064:09 pmRNSExercise of Options
13th Oct 20067:00 amPRNToumaz Debuts New Sensium(TM) Module
10th Oct 20063:58 pmRNSDirector/PDMR Shareholding
7th Sep 20065:12 pmPRNResult of AGM
7th Sep 20067:00 amPRNAppointment of CEO
6th Sep 20067:00 amPRNAGM Statement
23rd Aug 20067:00 amPRNStrategic Investment
18th Aug 20064:01 pmRNSHolding(s) in Company
3rd Jul 20067:00 amPRNDirectorate Change
30th Jun 20067:02 amRNSInterim Results
28th Apr 20067:00 amPRNFinal Results
21st Apr 20067:00 amPRNToumaz Appoints New CEO
13th Feb 200611:23 amRNSHolding(s) in Company
23rd Dec 20057:00 amPRNUpdate
11th Nov 20051:40 pmRNSHolding(s) in Company
9th Nov 20056:08 pmRNSHolding(s) in Company
7th Nov 200510:36 amRNSHolding(s) in Company
2nd Nov 20052:49 pmPRNResult of EGM
19th Oct 20051:35 pmRNSSchedule 1 - Nanoscience Inc
10th Oct 20056:00 amPRNAcquisition and Fundraising
10th Oct 20056:00 amPRNAcquisition and Fundraising
10th Oct 20056:00 amPRNAcquisition and Fundraising
21st Sep 20052:22 pmPRNInterim Results
31st Aug 200510:56 amPRNStrategic Investment
9th Jun 200510:00 amRNSRe Investment
3rd May 200512:17 pmRNSAppointment of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.